It highlights the prognostic and diagnostic value of integrating prothrombotic biomarkers, especially fibrinogen and CRP, into clinical practice, while also suggesting that their elevation may not be limited to infection but extend to exacerbation-related vascular pathology. Here, CRP is linked to infection.